Red Glead Discovery
Johan Evenäs, CEO
+46 46 4601291
Red Glead Discovery is a rapidly growing Scandinavian drug discovery CRO company with 23 employees. Our long-standing experience in preclinical development of compounds for inhalation makes us a preferred partner for clients that want to discover new drugs or to optimise existing substances for this administration route.
Our in-house capabilities span across a large part of the drug discovery process chain:
Custom Synthesis of small molecules and peptides
ADME & Analysis (incl. LC-MS/MS and NMR)
Assays & Screening / In vitro biology
Expertise in evaluation of compound effects in vivo inhalation models by histological endpoints
Fragment-based lead discovery
If you want to outsource whole projects, we can offer integrated drug discovery services. We use our experience gained from respiratory and inflammation R&D from the pharmaceutical industry combined with innovative practise in chemical synthesis to deliver compounds with high potential to become successful drugs for inhalation.